0001562180-19-004967.txt : 20190927
0001562180-19-004967.hdr.sgml : 20190927
20190927160530
ACCESSION NUMBER: 0001562180-19-004967
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190925
FILED AS OF DATE: 20190927
DATE AS OF CHANGE: 20190927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Laliberte Kevin
CENTRAL INDEX KEY: 0001709417
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38135
FILM NUMBER: 191122158
MAIL ADDRESS:
STREET 1: C/O DOVA PHARMACEUTICALS, INC.
STREET 2: 240 LEIGH FARM ROAD, SUITE 245
CITY: DURHAM
STATE: NC
ZIP: 27707
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dova Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001685071
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813858961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 240 LEIGH FARM ROAD
CITY: DURHAM
STATE: NC
ZIP: 27707
BUSINESS PHONE: 919-806-4487
MAIL ADDRESS:
STREET 1: 240 LEIGH FARM ROAD
CITY: DURHAM
STATE: NC
ZIP: 27707
FORMER COMPANY:
FORMER CONFORMED NAME: Dova Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20160919
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-09-25
false
0001685071
Dova Pharmaceuticals Inc.
DOVA
0001709417
Laliberte Kevin
C/O DOVA PHARMACEUTICALS, INC.
240 LEIGH FARM ROAD, SUITE 245
DURHAM
NC
27707
false
true
false
false
Sr. VP, Product Development
Common Stock
2019-09-25
4
S
false
3100.00
20.00
D
8457.00
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan based on a limit price order adopted by the Reporting Person.
/s/ Marc Banjak, Attorney-in-Fact
2019-09-27